Аннотация:
2-Thia-4-azabicyclo[3.3.1]non-3-en-3-amine was synthesized as a lipophilic analogue of NO-synthase inhibitor 2-amino-5,6-dihydro- 4H-1,3-thiazine and found to be a potent inhibitor of inducible NO-synthase in vitro. The crystal structure of the key intermediate 2-thia-4-azabicyclo[3.3.1]nonane-3-thione (obtained by cyclization of trans-3-bromocyclohexylamine with carbon disulfide) was determined by X-ray analysis.
Образец цитирования:
O. N. Zefirova, E. D. Plotnikova, E. V. Nurieva, D. I. Peregud, M. V. Onufriev, N. V. Gulyaeva, “Synthesis of 2-thia-4-azabicyclo[3.3.1]non-3-en-3-amine – bridged nitric oxide synthase inhibitor with enhanced lipophilicity”, Mendeleev Commun., 23:2 (2013), 76–77
Образцы ссылок на эту страницу:
https://www.mathnet.ru/rus/mendc2618
https://www.mathnet.ru/rus/mendc/v23/i2/p76
Эта публикация цитируется в следующих 11 статьяx:
Barbara Parrino, Stella Cascioferro, Daniela Carbone, Camilla Pecoraro, Girolamo Cirrincione, Patrizia Diana, Advances in Heterocyclic Chemistry, 136, 2022, 1
Barbara Parrino, Stella Cascioferro, Daniela Carbone, Girolamo Cirrincione, Patrizia Diana, Comprehensive Heterocyclic Chemistry IV, 2022, 150
Kseniya N. Sedenkova, Olga V. Ryzhikova, Svetlana A. Stepanova, Alexei D. Averin, Sergei V. Kositov, Yuri K. Grishin, Igor P. Gloriozov, Elena B. Averina, “Bis(oxiranes) Containing Cyclooctane Core: Synthesis and Reactivity towards NaN3”, Molecules, 27:20 (2022), 6889
Evgeniya V. Nurieva, Alexander A. Alexeev, Olga N. Zefirova, “Cyclic Isothiourea in Drug Design”, Chem Heterocycl Comp, 57:9 (2021), 889
Alexander A. Alexeev, Evgeniya V. Nurieva, Konstantin A. Lyssenko, Yuri K. Grishin, Olga N. Zefirova, “Novel structural type of bridged urea derivatives bearing azatricyclo[4.3.1.03,8]decane moiety”, Struct Chem, 30:2 (2019), 473
A. A. Alexeev, E. V. Nurieva, T. P. Trofimova, E. A. Chesnakova, Yu. K. Grishin, K. A. Lyssenko, M. V. Filimonova, O. N. Zefirova, “Bicyclic bridged isothioureas: synthesis and evaluation of activity in a model of lipopolysaccharide-induced septic shock”, Mendeleev Commun., 29:1 (2019), 14–16
E. V. Nurieva, T. P. Trofimova, A. A. Alexeev, A. N. Proshin, E. A. Chesnakova, Yu. K. Grishin, K. A. Lyssenko, M. V. Filimonova, S. O. Bachurin, O. N. Zefirova, “Synthesis and antihypotensive properties of 2-amino-2-thiazoline analogues with enhanced lipophilicity”, Mendeleev Commun., 28:4 (2018), 390–392
D. V. Shishov, E. V. Nurieva, N. S. Zefirov, A. V. Mamaeva, O. N. Zefirova, “Synthesis of 5-hydroxy-4-methoxytricyclo[7.3.1.02,7]trideca-2,4,6-trien- 8-one – precursor of putative bioisosteric colchicine analogues”, Mendeleev Commun., 24:6 (2014), 370–371
E. D. Plotnikova, E. V. Nurieva, D. I. Peregud, M. V. Onufriev, N. V. Gulyaeva, V. M. Makarchuk, M. V. Filimonova, N. S. Zefirov, O. N. Zefirova, “Molecular modeling, X-ray diffraction analysis, and the study of iNOS inhibitor activity of 3-imino-2,4-diazabicyclo[3.3.1]nonan-1-ol hydrochloride”, Russ J Org Chem, 49:8 (2013), 1108
O. N. Zefirova, N. S. Zefirov, “Targeted application of bridged fragments in the design of physiologically active compounds”, Russ Chem Bull, 62:2 (2013), 325
Olga N. Zefirova, Evgeniya D. Plotnikova, Evgeniya V. Nurieva, Danil I. Peregud, Mikhail V. Onufriev, Natalia V. Gulyaeva, “ChemInform Abstract: Synthesis of 2‐Thia‐4‐azabicyclo[3.3.1]non‐3‐en‐3‐amine — Bridged Nitric Oxide Synthase Inhibitor with Enhanced Lipophilicity.”, ChemInform, 44:31 (2013)